HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken-ichiro Inoue Selected Research

1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)

2/2013Effects of exposure to nanoparticle-rich or -depleted diesel exhaust on allergic pathophysiology in the murine lung.
1/2013Organic chemicals in diesel exhaust particles enhance picryl chloride-induced atopic dermatitis in NC/Nga mice.
1/2012Effects of nanoparticle-rich diesel exhaust particles on IL-17 production in vitro.
9/2011In vitro effects of nanoparticle-rich diesel exhaust particles on splenic mononuclear cells.
3/2011Biology of diesel exhaust effects on allergic pulmonary inflammation.
1/2011In vitro study of the effect of nanoparticle-rich diesel exhaust particles on IL-18 production in splenocytes.
11/2010Comprehensive analysis of elastase-induced pulmonary emphysema in mice: effects of ambient existing particulate matters.
2/2009Effects of diesel exhaust particles on antigen-presenting cells and antigen-specific Th immunity in mice.
1/2007Effects of diesel exhaust particles on cytokine production by splenocytes stimulated with lipopolysaccharide.
12/2006Effects of organic chemicals derived from ambient particulate matter on lung inflammation related to lipopolysaccharide.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken-ichiro Inoue Research Topics

Disease

22Inflammation (Inflammations)
02/2013 - 03/2004
14Pneumonia (Pneumonitis)
01/2013 - 04/2003
9Asthma (Bronchial Asthma)
02/2013 - 09/2007
9Acute Lung Injury
04/2010 - 11/2003
5Atopic Dermatitis (Atopic Eczema)
08/2014 - 08/2006
3Peritonitis
02/2013 - 09/2003
3Hemorrhage
01/2013 - 06/2004
3Infections
10/2011 - 03/2003
3Lung Diseases (Lung Disease)
03/2011 - 04/2003
3Lung Injury
11/2010 - 04/2002
3Pancreatitis
04/2010 - 01/2009
3Shock
04/2010 - 01/2009
3Disseminated Intravascular Coagulation
04/2010 - 01/2009
2Eosinophilia
10/2010 - 08/2010
2Body Weight (Weight, Body)
04/2007 - 04/2004
2Obesity
04/2007 - 10/2003
1Liver Diseases (Liver Disease)
01/2014
1Hepatocellular Carcinoma (Hepatoma)
01/2014
1Chronic Cough
02/2013
1Hypersensitivity (Allergy)
02/2013
1Dermatitis
02/2012
1Liver Abscess
01/2012
1Fibrosis (Cirrhosis)
03/2011
1Emphysema
11/2010
1Pulmonary Emphysema
11/2010
1Metaplasia
07/2009
1Allergic Rhinitis
09/2007
1Diabetes Mellitus
04/2007

Drug/Important Bio-Agent (IBA)

161-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
02/2013 - 04/2002
14CytokinesIBA
01/2013 - 11/2004
14LipopolysaccharidesIBA
05/2011 - 11/2003
13Vehicle Emissions (Emissions, Vehicle)IBA
01/2013 - 04/2002
7AllergensIBA
08/2014 - 08/2006
7EndotoxinsIBA
05/2011 - 04/2004
5ChemokinesIBA
07/2009 - 01/2004
4MetallothioneinIBA
01/2013 - 03/2006
3OvalbuminIBA
02/2013 - 07/2009
3Chemotactic FactorsIBA
02/2013 - 04/2004
3Diethylhexyl Phthalate (DEHP)IBA
02/2013 - 08/2006
3Organic Chemicals (Chemicals, Organic)IBA
01/2013 - 11/2004
3AntigensIBA
02/2012 - 09/2005
3Particulate MatterIBA
10/2011 - 12/2006
3InterleukinsIBA
03/2011 - 06/2004
3Proteins (Proteins, Gene)FDA Link
11/2010 - 04/2004
3urinastatin (MR 20)IBA
04/2010 - 01/2009
3Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
04/2010 - 01/2009
3Immunoglobulins (Immunoglobulin)IBA
06/2009 - 03/2004
3Rosmarinic AcidIBA
07/2006 - 04/2003
3Interleukin-6 (Interleukin 6)IBA
06/2006 - 10/2003
2PlasticizersIBA
08/2014 - 05/2009
2Biomarkers (Surrogate Marker)IBA
01/2014 - 04/2002
2Therapeutic UsesIBA
06/2012 - 05/2011
2SandIBA
01/2012 - 10/2010
2InflammasomesIBA
01/2012 - 10/2010
2AntioxidantsIBA
10/2009 - 04/2004
2phthalic acid (phthalate)IBA
05/2009 - 08/2006
2Hemostatics (Antihemorrhagics)IBA
06/2006 - 06/2004
2Vitamin EFDA LinkGeneric
10/2004 - 04/2004
1butylphenIBA
08/2014
1Surface-Active Agents (Surfactants)IBA
08/2014
14-tert-octylphenolIBA
08/2014
14-nonylphenolIBA
08/2014
1Indicators and Reagents (Reagents)IBA
01/2014
1Gabapentin (Neurontin)FDA LinkGeneric
02/2013
1Interleukin-5 (Interleukin 5)IBA
02/2013
1pinacolyl methylphosphonochloridate (PICL)IBA
01/2013
1Immunoglobulin E (IgE)IBA
01/2013
1Picryl Chloride (Trinitrochlorobenzene)IBA
01/2013
1DoripenemFDA Link
01/2012
1EucalyptolIBA
05/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2011
1CC ChemokinesIBA
03/2011
1LigandsIBA
03/2011
1Cholinergic Agents (Cholinergics)IBA
11/2010
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2010
1CobaltIBA
11/2010
1Alkaline PhosphataseIBA
11/2010
1Methacholine Chloride (Methacholine)FDA Link
11/2010
1Pancreatic Elastase (Elastase)IBA
11/2010
1Hypoxia-Inducible Factor 1IBA
11/2010
1diisononyl phthalateIBA
04/2010
1Dacarbazine (DIC)FDA LinkGeneric
04/2010
1Thymic Stromal LymphopoietinIBA
04/2010
1PeroxiredoxinsIBA
10/2009
1EnzymesIBA
10/2009
1Interleukin-2 (IL2)IBA
10/2009
1beta-GlucansIBA
07/2009
1Interleukin-17 (Interleukin 17)IBA
07/2009
1Carbon Nanotubes (Carbon Nanotube)IBA
06/2009
1EstersIBA
05/2009
1Peptide Hydrolases (Proteases)FDA Link
01/2009
1LatexIBA
01/2009
1Free Radical ScavengersIBA
12/2008
1OzoneIBA
12/2008
1CarbonIBA
09/2007
1Butylated Hydroxytoluene (BHT)IBA
09/2007
1FructosamineIBA
04/2007
1Blood Glucose (Blood Sugar)IBA
04/2007
1Proanthocyanidins (Procyanidins)IBA
04/2007
1alpha-2-Antiplasmin (alpha 2 Antiplasmin)IBA
06/2006